Cerenome Inc. Common Stock (CNSY)
CNSY trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1095981/000119312526104258/0001193125-26-104258-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | CNSY on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001095981 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $5.2M |
| Net income | -$22.4M |
| Operating income | -$15.3M |
| Net margin | -429.4% |
| Operating margin | -293.5% |
| Revenue growth | -10.5% |
| Cash | $4.3M |
| Total assets | $16.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.3× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors raise substantial doubt about the Company's ability to continue as a going concern. 11 Table of Contents As disclosed in more detail in Note 13 Stockholders' Equity , the Company has entered into various financing agreements to raise capital." | 10-Q 2026-11-13 |
| Cash and burn | $2.4M cash; operating cash flow -$5.5M a quarter. | Report 2026-06-30 |
| Shares outstanding | 9,776,935 (2026-11-09); 137,429,055 a year earlier; 4,522,656 three years earlier. 1y figure adjusted for splits (1-for-25 overall); 3y figure adjusted for splits (1-for-25 overall). | Cover page 2026-11-09 |
| Reverse splits, 3 years | 1; latest 1-for-25 on 2026-04-02 | Source 2026-04-02 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-06-02 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | CBIZ CPAs P.C., New York, New York, United States; changed auditors 1 time in 24 months | 8-K 4.01 2025-07-18 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $10K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $411K | -$9.0M | -$7.1M | $2.4M | No debt tags | $4.2M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $1.0M | -$6.9M | -$6.2M | $3.0M | No debt tags | $5.2M | 10-Q 2026-05-15 |
| Q4 2025 2025-12-31 | $1.4M | -$5.7M | -$6.3M | $4.3M | No debt tags | $5.2M | 10-K 2026-03-12 |
| Q3 2025 2025-09-30 | $1.4M | -$4.4M | -$2.5M | $13.3M | No debt tags | $5.3M | 10-Q 2025-10-30 |
| Q2 2025 2025-06-30 | $1.4M | $5.2M | -$5.8M | $2.2M | No debt tags | $5.3M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $1.1M | -$17.4M | -$6.2M | $9.9M | No debt tags | $5.2M | 10-Q 2026-05-15 |
| Q4 2024 2024-12-31 | $1.4M | -$3.9M | -$1.2M | $76K | No debt tags | $5.8M | 10-K 2026-03-12 |
| Q3 2024 2024-09-30 | $1.5M | -$2.9M | -$3.7M | $1.2M | No debt tags | Needs four quarters | 10-Q 2025-10-30 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-06-02 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report | 8-K | 2026-11-16 |
| Latest proxy | DEFA14A | 2026-03-31 |
Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +48.4% |
| 1 month | -45.4% |
| 3 months | -74.3% |
| Year to date | -92.5% |
| 1 year | -92.7% |
| From 52-week high | -94.7% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NMTC | NeuroOne Medical Technologies Corporation | $0.7450 | -0.01% | $6.8M |
| ARAY | Accuray Incorporated | $2.55 | -8.93% | $7.7M |
| AEMD | Aethlon Medical Inc. | $5.01 | -5.29% | $8.1M |
| WOK | WORK Medical Technology Group LTD | $1.23 | +2.50% | $5.5M |
| PLSM | Pulsenmore Ltd. | $1.41 | +2.17% | $9.2M |
| INBS | Intelligent Bio Solutions Inc. | $1.50 | -16.20% | $5.0M |
| SINT | SiNtx Technologies Inc. | $1.34 | -1.11% | $10.1M |
| ICU | SeaStar Medical Holding Corporation | $0.8535 | +1.80% | $4.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier